Does Ozempic Cause Cancer?
Ozempic and other GLP-1 drugs carry a real cancer warning — but the human data now tell a much more surprising story. In this video, I explain what we actually know about GLP-1 drugs like Ozempic, semaglutide, thyroid cancer, pancreatic cancer, obesity-related cancers, cancer progression, and immunotherapy outcomes. The key point: Ozempic is not a cancer treatment, and nobody should start it to prevent or treat cancer. But the evidence is becoming more interesting than the old warning label alone suggests. We’ll cover: Where the original cancer warning came from Why rodent thyroid cancer findings may not translate directly to humans What newer human safety studies show Why obesity, insulin resistance, inflammation, and fatty liver disease matter for cancer risk New ASCO 2026 data on GLP-1 drugs and cancer progression Early real-world data on GLP-1 drugs with immunotherapy Why these findings are promising but not proof ▶️ Subscribe to my youtube channel: / @drchovanec 👉 Free Biopsy Checklist (1 page) If your doctor mentioned a prostate biopsy — don’t go in unprepared. This 1-page checklist helps you ask the right questions before you decide. Download and print it here: https://drchovanec.kit.com/30968ddb5c 📘 Optional PSA Guide (14 pages) If you want a clear step-by-step framework — from PSA to MRI to biopsy decisions — I’ve organized everything into a simple printable guide. All the information is explained for free in my videos. This just puts it into one structured plan you can actually use. https://chovano.gumroad.com/l/luikhi This video is for education only and is not personal medical advice. If you are taking a GLP-1 drug, considering one, or undergoing cancer treatment, discuss your situation with your doctor. References: Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown. Nature Reviews Clinical Oncology. 2026. DOI: 10.1038/s41571-026-01135-0 Orland MD, et al. GLP-1 receptor agonists and metastatic progression in obesity-related cancers. ASCO Annual Meeting 2026, Abstract 3143. Jajja S, Thukral J, Abdalla A, et al. The association of GLP-1 receptor agonist use with survival and immune-related adverse events in patients receiving immune checkpoint inhibitors. J Clin Oncol. 2026;44(suppl 16):11000. DOI: 10.1200/JCO.2026.44.16_suppl.11000 Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study. Diabetes Care. 2025;48(8):1386. #OzempicCancer #GLP1Drugs #GLP1Agonist #Wegovy #WeightLossDrugs #ObesityAndCancer #CancerRisk #ThyroidCancer #PancreaticCancer #Immunotherapy #CancerResearch #ASCO2026 #CancerTreatment #CancerSurvivorship #MetabolicHealth #InsulinResistance #CancerScience #MedicalOncology #Ozempic #Cancer #GLP1 #Semaglutide #CancerPrevention
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
Germans DO Have a Sense of Humour - Jimmy Carr Meets a Frankfurt Audience
The Hidden Danger Of Raising Chimps (4K Documentary)
The next frontier of the Ozempic revolution is here. But experts warn of psychological impacts
5 Prostate Symptoms That Usually Aren’t Cancer
Your Prostate Needs More Than PSA
Ozempic & Mounjaro: Same Shot. Opposite Results.
It's NOT Memory - 5 Early Dementia Signs Everyone Misses
300 Secret Historical Photos You Were Never Supposed to See
Vitamin D Expert: The Fastest Way To Dementia & The Big Lie About Sunlight!
PI-RADS Explained: What Your Prostate MRI Result Really Means
The 10 Best Foods That Make Ozempic & Zepbound Work FASTER! Weight Loss Doctor Explains
The Golden Age of Second Passports Is Over, Here's What Happens Next
Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)
Dr. Explains Why Retatrutide is KING of Fat Loss Peptides
This Common Food Is Feeding Your Cancer Cells - Dr. William Li
The Patient That Changed My Entire Career Forever.
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List
The Silent Signs Of Breast Cancer
